{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:51:30Z","timestamp":1772481090291,"version":"3.50.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/cji.0b013e31819b7c30","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T13:26:00Z","timestamp":1242912360000},"page":"310-321","source":"Crossref","is-referenced-by-count":36,"title":["Activated Human \u03b3\u03b4 T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes"],"prefix":"10.1097","volume":"32","author":[{"given":"Silke","family":"Landmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Altvater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Pscherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Varnholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hansmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Moosmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Bisping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rossig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210227","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","article-title":"Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer","volume":"110","author":"Bollard","year":"2007","journal-title":"Blood"},{"key":"R2-11-20210227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"key":"R3-11-20210227","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.175.6.4137","article-title":"Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma","volume":"175","author":"Straathof","year":"2005","journal-title":"J Immunol"},{"key":"R4-11-20210227","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone-marrow-derived cells in presenting MHC class I-restricted tumor-antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"R5-11-20210227","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R6-11-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.leu.2404146","article-title":"Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients","volume":"20","author":"Maecker","year":"2006","journal-title":"Leukemia"},{"key":"R7-11-20210227","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R8-11-20210227","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm869","article-title":"Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells","volume":"9","author":"Oelke","year":"2003","journal-title":"Nat Med"},{"key":"R9-11-20210227","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","article-title":"CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy","volume":"100","author":"Schultze","year":"1997","journal-title":"J Clin Invest"},{"key":"R10-11-20210227","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gamma delta T cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"R11-11-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"Gamma\/delta T-cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N Engl J Med"},{"key":"R12-11-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human gamma delta T cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"R13-11-20210227","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/clin.1997.4468","article-title":"Gamma delta T cells in host defense and epithelial cell biology","volume":"86","author":"Boismenu","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"R14-11-20210227","first-page":"124","article-title":"TCR gamma delta+ T cells in peripheral blood of patients with adult Still's disease","volume":"23","author":"Hoshino","year":"1996","journal-title":"J Rheumatol"},{"key":"R15-11-20210227","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.1978758","article-title":"Recognition by human V gamma 9\/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells","volume":"250","author":"Fisch","year":"1990","journal-title":"Science"},{"key":"R16-11-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","article-title":"Human T cell receptor gamma delta cells recognize endogenous mevalonate metabolites in tumor cells","volume":"197","author":"Gober","year":"2003","journal-title":"J Exp Med"},{"key":"R17-11-20210227","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/eji.1830220310","article-title":"Gamma\/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors","volume":"22","author":"Nanno","year":"1992","journal-title":"Eur J Immunol"},{"key":"R18-11-20210227","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R19-11-20210227","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane-protein expression in Hodgkin and Reed-Sternberg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-11-20210227","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"Kuppers","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R21-11-20210227","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/mp.53.5.248","article-title":"Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma","volume":"53","author":"Niedobitek","year":"2000","journal-title":"J Clin Pathol Mol Pathol"},{"key":"R22-11-20210227","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","article-title":"Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis","volume":"90","author":"Niedobitek","year":"1997","journal-title":"Blood"},{"key":"R23-11-20210227","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ijc.1396","article-title":"Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma","volume":"93","author":"Gahn","year":"2001","journal-title":"Int J Cancer"},{"key":"R24-11-20210227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"R25-11-20210227","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/hum.1996.7.12-1405","article-title":"Episomal vectors rapidly and stably produce high-titer recombinant retrovirus","volume":"7","author":"Kinsella","year":"1996","journal-title":"Hum Gene Ther"},{"key":"R26-11-20210227","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells","volume":"92","author":"Riviere","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-11-20210227","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.1457","article-title":"Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes","volume":"94","author":"Rossig","year":"2001","journal-title":"Int J Cancer"},{"key":"R28-11-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2141.2004.05077.x","article-title":"Human gamma delta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity","volume":"126","author":"Rischer","year":"2004","journal-title":"Br J Haematol"},{"key":"R29-11-20210227","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.1158\/0008-5472.CAN-06-4426","article-title":"Gene-engineered varicella-zoster virus-reactive CD4+ cytotoxic T cells exert tumor-specific effector function","volume":"67","author":"Landmeier","year":"2007","journal-title":"Cancer Res"},{"key":"R30-11-20210227","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.20011692","article-title":"Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection","volume":"195","author":"Hislop","year":"2002","journal-title":"J Exp Med"},{"key":"R31-11-20210227","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1128\/JVI.67.12.7428-7435.1993","article-title":"HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2","volume":"67","author":"Lee","year":"1993","journal-title":"J Virol"},{"key":"R32-11-20210227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1615\/CritRevImmunol.v17.i1.40","article-title":"Accessory molecule and costimulation requirements for CD4 T cell response","volume":"17","author":"Croft","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"R33-11-20210227","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human gamma delta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Res"},{"key":"R34-11-20210227","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20041542","article-title":"CD8(+) immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells","volume":"201","author":"Pudney","year":"2005","journal-title":"J Exp Med"},{"key":"R35-11-20210227","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2002-04-1230","article-title":"Antigen presentation by mouse CD4(+) T cells involving acquired MHC class II peptide complexes: another mechanism to limit clonal expansion?","volume":"101","author":"Tsang","year":"2003","journal-title":"Blood"},{"key":"R36-11-20210227","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J Virol"},{"key":"R37-11-20210227","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20040121","article-title":"CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"R38-11-20210227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.cji.0000211325.30525.84","article-title":"Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells","volume":"30","author":"Leen","year":"2007","journal-title":"J Immunother"},{"key":"R39-11-20210227","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.4049\/jimmunol.178.9.5465","article-title":"Human CD4(+) T cells displaying viral epitopes elicit a functional virus-specific memory CD8(+) T cell response","volume":"178","author":"Adamopoulou","year":"2007","journal-title":"J Immunol"},{"key":"R40-11-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-1759(03)00209-6","article-title":"Monitoring CD4(+) T cell responses against viral and tumor antigens using T cells as novel target APC","volume":"278","author":"Atanackovic","year":"2003","journal-title":"J Immunol Methods"},{"key":"R41-11-20210227","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CJI.0b013e318046f3b1","article-title":"Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12","volume":"30","author":"Foster","year":"2007","journal-title":"J Immunother"},{"key":"R42-11-20210227","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2007-02-072843","article-title":"Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes","volume":"110","author":"Quintarelli","year":"2007","journal-title":"Blood"},{"key":"R43-11-20210227","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gamma delta T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"key":"R44-11-20210227","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2004-01-0331","article-title":"Fc gamma RIII discriminates between 2 subsets of V gamma 9V delta 2 effector cells with different responses and activation pathways","volume":"104","author":"Angelini","year":"2004","journal-title":"Blood"},{"key":"R45-11-20210227","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nm1352","article-title":"Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity","volume":"12","author":"Chan","year":"2006","journal-title":"Nat Med"},{"key":"R46-11-20210227","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.20070021","article-title":"Tumoricidal activity of TLR7\/8-activated inflammatory dendritic cells","volume":"204","author":"Stary","year":"2007","journal-title":"J Exp Med"},{"key":"R47-11-20210227","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1356","article-title":"A novel dendritic cell subset involved in tumor immunosurveillance","volume":"12","author":"Taieb","year":"2006","journal-title":"Nat Med"},{"key":"R48-11-20210227","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/86523","article-title":"Therapy of human tumors in NOD\/SCID mice with patient-derived reactivated memory T cells from bone marrow","volume":"7","author":"Feuerer","year":"2001","journal-title":"Nat Med"},{"key":"R49-11-20210227","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2006-01-023127","article-title":"Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches","volume":"108","author":"Greiner","year":"2006","journal-title":"Blood"},{"key":"R50-11-20210227","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e31819b7c30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:03:20Z","timestamp":1621886600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200904000-00011"}},"subtitle":["Potential for Immunotherapy of Cancer"],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e31819b7c30","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}